Program for managing knee osteoarthritis in primary care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of a Chronic Care Model called the Risk Assessment and Management Program on Knee Osteoarthritis (RAMP-Knee OA) in adults suffering from knee osteoarthritis. Participants will be randomly assigned to either the RAMP-Knee OA group, which includes structured support and consultations, or a usual care group. The study will assess various outcomes, including pain relief and improvements in physical function and quality of life, over a 52-week period. Participants will undergo assessments at baseline, and at 16, 32, and 52 weeks to measure the program's impact.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of Knee OA based on clinical criteria of the American Rheumatology College
* Moderate to severe Knee pain for 3 months or longer (average score of 4 or greater on a 0-10 pain scale in the past 3 months)

Exclusion Criteria:

* Participants with potential serious knee pathology (e.g. inflammatory arthritis, acute trauma, malignancy)
* Previous Knee replacement
* Scheduled knee joint replacement surgery within 1 year
* Participants who are unable to reliably participate (e.g. those who do not speak Chinese or unable to attend study intervention)

Where it's running

• Lek Yuen GOPC
  Hong Kong, Hong Kong Recruiting

Study contacts

• Principal investigator: Regina Wing Shan SIT, M.D. — Jockey Club School of Public Health and Primary Care, Chinese University of Hong Kong
• Study coordinator: Cheryl Lok Chee Fung, Bachelor
• Email: cheryllcfung@cuhk.edu.hk
• Phone: 2609 5050

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effects of virtual reality on walking in adults with knee osteoarthritis

  This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.

  Recruiting University of Primorska · Vilnius and 1 other locations · NCT07920120

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

• Autologous adipose-derived stem cell injections for knee osteoarthritis

  We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.

  Recruiting at 3 sites Yonsei University · Incheon and 2 other locations · NCT07901790

• Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty

  This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.

  Recruiting Balikesir Ataturk City Hospital · Balıkesir · NCT07882316

• Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status

  Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.

  Recruiting Sisli Hamidiye Etfal Training and Research Hospital · Istanbul, Istanbul · NCT07881861

• Lysyl Enzymes in Knee Osteoarthritis

  This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.

  Recruiting Afyonkarahisar Health Sciences University · Afyonkarahisar · NCT07875296

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.